254 related articles for article (PubMed ID: 28266565)
1. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.
Lee H; Jeong M; Oh J; Cho Y; Shen X; Stone J; Yan J; Rothkopf Z; Khan AS; Cho BM; Park YK; Weiner DB; Son WC; Maslow JN
Sci Rep; 2017 Mar; 7():43531. PubMed ID: 28266565
[TBL] [Abstract][Full Text] [Related]
2. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination.
Arcuri M; Cappelletti M; Zampaglione I; Aurisicchio L; Nicosia A; Ciliberto G; Fattori E
J Gene Med; 2008 Sep; 10(9):1048-54. PubMed ID: 18655231
[TBL] [Abstract][Full Text] [Related]
4. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
5. DNA-based immunization breaks tolerance in a hepatitis C virus transgenic mouse model.
Encke J; Geissler M; Stremmel W; Wands JR
Hum Vaccin; 2006; 2(2):78-83. PubMed ID: 17012868
[TBL] [Abstract][Full Text] [Related]
6. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
7. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
[TBL] [Abstract][Full Text] [Related]
11. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
[TBL] [Abstract][Full Text] [Related]
12. Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein.
Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
J Gen Virol; 2001 Jun; 82(Pt 6):1299-1308. PubMed ID: 11369873
[TBL] [Abstract][Full Text] [Related]
13. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A; Fu TM; Bett A; Colloca S; Cortese R; Nicosia A; Folgori A
J Virol; 2006 Feb; 80(4):1688-99. PubMed ID: 16439526
[TBL] [Abstract][Full Text] [Related]
14. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
Encke J; zu Putlitz J; Geissler M; Wands JR
J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
[TBL] [Abstract][Full Text] [Related]
16. Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.
Youn JW; Park SH; Cho JH; Sung YC
J Virol; 2003 Nov; 77(21):11596-602. PubMed ID: 14557645
[TBL] [Abstract][Full Text] [Related]
17. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
18. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
Zhu LX; Liu J; Ye Y; Xie YH; Kong YY; Li GD; Wang Y
World J Gastroenterol; 2004 Sep; 10(17):2488-92. PubMed ID: 15300890
[TBL] [Abstract][Full Text] [Related]
19. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
[TBL] [Abstract][Full Text] [Related]
20. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
Encke J; zu Putlitz J; Stremmel W; Wands JR
Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
